Iron Depletion: An Ameliorating Factor for Sickle Cell Disease?
Author(s) -
Paola Giordano,
Wim Huisman,
Cornelis L. Harteveld
Publication year - 2011
Publication title -
isrn hematology
Language(s) - English
Resource type - Journals
eISSN - 2090-4428
pISSN - 2090-441X
DOI - 10.5402/2011/473152
Subject(s) - disease , medicine , chelation therapy , cell , intensive care medicine , immunology , thalassemia , biology , genetics
We report some observations from our laboratory practice that might be important for the treatment of sickle cell disease (SCD). We describe data from two cases indicating that iron depletion might have a beneficial effect diminishing the formation of HbS in favor of HbF, possibly reducing the severity of the disease. We believe that it would be worthwhile to monitor the course of the disease comparing cases with identical genotypes with and without iron depletion, and we advise to consider chelation therapy to reduce iron overload in patients with SCD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom